McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a February 2, 2017 edition of In-PharmaTechnologist.com in an article entitled, “Patheon well-placed if Trump suceeds in bringing manufacturing home, analyst.” Patheon could reap the benefits of President Donald Trump’s call for increased drug production in the US by upping capacity utilisation an analyst says. View the article
